Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshihito Tashiro

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Clinical and Experimental Nephrology|June 23, 2014
Nicorandil suppresses urinary protein excretion and activates eNOS in Dahl salt-sensitive hypertensive ratsYoshihito Tashiro, Kenji Yogo, Kenichi Serizawa, et al.
BMC Nephrology|January 29, 2018
Epoetin beta pegol for treatment of anemia ameliorates deterioration of erythrocyte quality associated with chronic kidney diseaseKen Aizawa, Ryohei Kawasaki, Yoshihito Tashiro, et al.
Pharmacology|March 20, 2014
GATA-4 transcription factor regulates cardiac COX-2 expression induced by nicorandil in left ventricle of ratsKenichi Serizawa, Kenji Yogo, Yoshihito Tashiro, et al.
Cardiovascular Diabetology|November 24, 2011
Nicorandil prevents endothelial dysfunction due to antioxidative effects via normalisation of NADPH oxidase and nitric oxide synthase in streptozotocin diabetic ratsKen-ichi Serizawa, Kenji Yogo, Ken Aizawa, et al.
Journal of Nephrology|May 14, 2014
Renoprotective effect of epoetin beta pegol by the prevention of M2 macrophage recruitment in Thy-1 ratsKen Aizawa, Yoshihito Tashiro, Michinori Hirata, et al.
Physiological Reports|December 5, 2015
Epoetin beta pegol alleviates oxidative stress and exacerbation of renal damage from iron deposition, thereby delaying CKD progression in progressive glomerulonephritis ratsMichinori Hirata, Yoshihito Tashiro, Ken Aizawa, et al.
International Journal of Hematology|April 17, 2016
Epoetin beta pegol, but not recombinant erythropoietin, retains its hematopoietic effect in vivo in the presence of the sialic acid-metabolizing enzyme sialidaseKen Aizawa, Ryohei Kawasaki, Yoshihito Tashiro, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 28, 2023
The in vitro effect of anticoagulant agents on coagulation and fibrinolysis in the presence of emicizumab in the plasmas from patients with haemophilia ATomoko Onishi, Suguru Harada, Hanako Shimo, et al.
Pharmacology|January 12, 2013
Nicorandil ameliorated hypertensive renal injury without lowering blood pressure in spontaneously hypertensive ratsKenichi Serizawa, Kenji Yogo, Yoshihito Tashiro, et al.
European Journal of Pharmacology|October 4, 2015
Epoetin beta pegol prevents endothelial dysfunction as evaluated by flow-mediated dilation in chronic kidney disease ratsKenichi Serizawa, Kenji Yogo, Yoshihito Tashiro, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Clinical and Experimental Nephrology|June 23, 2014
Nicorandil suppresses urinary protein excretion and activates eNOS in Dahl salt-sensitive hypertensive ratsYoshihito Tashiro, Kenji Yogo, Kenichi Serizawa, et al.
BMC Nephrology|January 29, 2018
Epoetin beta pegol for treatment of anemia ameliorates deterioration of erythrocyte quality associated with chronic kidney diseaseKen Aizawa, Ryohei Kawasaki, Yoshihito Tashiro, et al.
Pharmacology|March 20, 2014
GATA-4 transcription factor regulates cardiac COX-2 expression induced by nicorandil in left ventricle of ratsKenichi Serizawa, Kenji Yogo, Yoshihito Tashiro, et al.
Cardiovascular Diabetology|November 24, 2011
Nicorandil prevents endothelial dysfunction due to antioxidative effects via normalisation of NADPH oxidase and nitric oxide synthase in streptozotocin diabetic ratsKen-ichi Serizawa, Kenji Yogo, Ken Aizawa, et al.
Journal of Nephrology|May 14, 2014
Renoprotective effect of epoetin beta pegol by the prevention of M2 macrophage recruitment in Thy-1 ratsKen Aizawa, Yoshihito Tashiro, Michinori Hirata, et al.
Physiological Reports|December 5, 2015
Epoetin beta pegol alleviates oxidative stress and exacerbation of renal damage from iron deposition, thereby delaying CKD progression in progressive glomerulonephritis ratsMichinori Hirata, Yoshihito Tashiro, Ken Aizawa, et al.
International Journal of Hematology|April 17, 2016
Epoetin beta pegol, but not recombinant erythropoietin, retains its hematopoietic effect in vivo in the presence of the sialic acid-metabolizing enzyme sialidaseKen Aizawa, Ryohei Kawasaki, Yoshihito Tashiro, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 28, 2023
The in vitro effect of anticoagulant agents on coagulation and fibrinolysis in the presence of emicizumab in the plasmas from patients with haemophilia ATomoko Onishi, Suguru Harada, Hanako Shimo, et al.
Pharmacology|January 12, 2013
Nicorandil ameliorated hypertensive renal injury without lowering blood pressure in spontaneously hypertensive ratsKenichi Serizawa, Kenji Yogo, Yoshihito Tashiro, et al.
European Journal of Pharmacology|October 4, 2015
Epoetin beta pegol prevents endothelial dysfunction as evaluated by flow-mediated dilation in chronic kidney disease ratsKenichi Serizawa, Kenji Yogo, Yoshihito Tashiro, et al.
Pageof 3